Intended Use

AliveCor’s Corvair ECG analysis system assists healthcare professionals in measuring and interpreting resting diagnostic ECGs for rhythm and morphological information by providing an initial automated interpretation, intended as an adjunct to clinical findings and requiring physician review.

Technology

Corvair is a software medical device that analyzes a 10-second diagnostic-bandwidth ECG using deep neural networks trained on approximately 1 million ECGs. It supports analysis of 4 leads using signal processing and machine learning to provide 35 rhythm and morphology determinations, interfaced via an API library for integration into target devices.

Performance

Corvair underwent extensive nonclinical testing comparing its diagnostic performance (sensitivity, specificity, PPV) against a large dataset and a predicate device (K141963). Interval estimation was validated with standard ECG databases. No clinical testing was conducted. A Predetermined Change Control Plan enables ongoing algorithm improvements.

Predicate Devices

No predicate devices specified

Device Timeline

  • 1

    Submission

    4/7/2023

    1 year, 2 months
  • 2

    FDA Approval

    6/7/2024

Other devices from AliveCor, Inc.

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.